Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment

To date, few data are available regarding Adverse events (AEs) in cancer patients who are vaccinated for coronavirus disease 2019 (COVID-19) while being actively treated with Immune-checkpoint inhibitors (ICIs). We aimed to assess the safety of COVID-19 vaccines approved in Germany. Specifically, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Strobel, Sophia B., Machiraju, Devayani, Kälber, Katharina A., Hassel, Jessica C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695667/
https://www.ncbi.nlm.nih.gov/pubmed/34940894
http://dx.doi.org/10.1007/s00262-021-03133-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695667/
https://www.ncbi.nlm.nih.gov/pubmed/34940894
http://dx.doi.org/10.1007/s00262-021-03133-w

Ejemplares similares